Knight Therapeutics | GUD - 営業経費

株価
6.15
毎日の変更
0.01 0.16%
毎月
-6.11%
毎年
-0.65%
Q1 予測
5.95




営業経費 変化する 日付
Acasti Pharma USD 62.82M 59.73M 2025-09
Akebia Therapeutics USD 43.82M 16.98M 2025-03
Alaunos Therapeutics USD 1.19M 428K 2025-09
Aurora Cannabis CAD 146.03M 27.79M 2025-09
Avita Medical AUD 28.02M 1.55M 2025-12
Canopy Growth CAD 80.99M 8.64M 2025-09
Cronos Group USD 51.59M 70.5M 2025-12
Dianthus Therapeutics USD 40.68M 5.56M 2025-09
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Knight Therapeutics CAD 118.61M 11.79M 2025-09
Moderna USD 1.54B 259M 2025-12
Omeros USD 59.16M 20.13M 2024-06
Organigram Holdings CAD 108.11M 17.03M 2025-09
Organon & Co USD 906M 362M 2025-09
Revvity USD 626.22M 25.62M 2025-12
Tectonic Therapeutic USD 21.89M 440K 2025-09
Tilray USD 237.52M 17.34M 2025-09
Viatris USD 3.86B 335.7M 2025-12
Xeris Pharmaceuticals USD 67.65M 590K 2025-09